Global Huntington's Disease Treatment Supply, Demand and Key Producers, 2023-2029
The global Huntington's Disease Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Huntington's disease is an infrequent inherited neurodegenerative disease that affects various generations. The impact of this disease is high when the age is between 30 and 50, hampering their ability to work, care for families, and eventually complete daily tasks. The generality difers by more than ten-fold between geographical areas, which can be associated with differences in case ascertainments and diagnostic criteria. As a result, the generality of enlarged replications in the general population may be larger than expected. The Asian population has continuously had a lower generality, while Europe, North America, and Australia have a higher generality.
This report studies the global Huntington's Disease Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Huntington's Disease Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Huntington's Disease Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Huntington's Disease Treatment total production and demand, 2018-2029, (K Units)
Global Huntington's Disease Treatment total production value, 2018-2029, (USD Million)
Global Huntington's Disease Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Huntington's Disease Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Huntington's Disease Treatment domestic production, consumption, key domestic manufacturers and share
Global Huntington's Disease Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Huntington's Disease Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Huntington's Disease Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Huntington's Disease Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AInylam Pharmaceuticals Inc, AmpliPhi Biosciences Corp, Ceregene Inc, Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd, Cortex Pharmaceuticals Inc, Vertex Pharmaceuticals Incorporated and Auspex Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Huntington's Disease Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Huntington's Disease Treatment Market, By Region:
1. How big is the global Huntington's Disease Treatment market?
2. What is the demand of the global Huntington's Disease Treatment market?
3. What is the year over year growth of the global Huntington's Disease Treatment market?
4. What is the production and production value of the global Huntington's Disease Treatment market?
5. Who are the key producers in the global Huntington's Disease Treatment market?
6. What are the growth factors driving the market demand?
Huntington's disease is an infrequent inherited neurodegenerative disease that affects various generations. The impact of this disease is high when the age is between 30 and 50, hampering their ability to work, care for families, and eventually complete daily tasks. The generality difers by more than ten-fold between geographical areas, which can be associated with differences in case ascertainments and diagnostic criteria. As a result, the generality of enlarged replications in the general population may be larger than expected. The Asian population has continuously had a lower generality, while Europe, North America, and Australia have a higher generality.
This report studies the global Huntington's Disease Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Huntington's Disease Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Huntington's Disease Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Huntington's Disease Treatment total production and demand, 2018-2029, (K Units)
Global Huntington's Disease Treatment total production value, 2018-2029, (USD Million)
Global Huntington's Disease Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Huntington's Disease Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Huntington's Disease Treatment domestic production, consumption, key domestic manufacturers and share
Global Huntington's Disease Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Huntington's Disease Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Huntington's Disease Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Huntington's Disease Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AInylam Pharmaceuticals Inc, AmpliPhi Biosciences Corp, Ceregene Inc, Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd, Cortex Pharmaceuticals Inc, Vertex Pharmaceuticals Incorporated and Auspex Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Huntington's Disease Treatment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Huntington's Disease Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tetrabenazine
- Selective Serotonin Reuptake Inhibitor
- Chlorpromazine
- Haloperidol
- Risperidone
- Olanzapine
- Clozapine
- Other
- Hospital
- Specialty Clinic
- other
- AInylam Pharmaceuticals Inc
- AmpliPhi Biosciences Corp
- Ceregene Inc
- Lundbeck
- Prana Biotechnology Limited
- Teva Pharmaceutical Industries Ltd
- Cortex Pharmaceuticals Inc
- Vertex Pharmaceuticals Incorporated
- Auspex Pharmaceuticals
- SOM Biotech
- GlaxoSmithKline
- Siena Biotech
- Raptor Pharmaceutical
- Pfizer
- Palobiofarma
- Omeros
- Ipsen
- Valeant Pharmaceuticals International Inc
1. How big is the global Huntington's Disease Treatment market?
2. What is the demand of the global Huntington's Disease Treatment market?
3. What is the year over year growth of the global Huntington's Disease Treatment market?
4. What is the production and production value of the global Huntington's Disease Treatment market?
5. Who are the key producers in the global Huntington's Disease Treatment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Huntington's Disease Treatment Introduction
1.2 World Huntington's Disease Treatment Supply & Forecast
1.2.1 World Huntington's Disease Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Huntington's Disease Treatment Production (2018-2029)
1.2.3 World Huntington's Disease Treatment Pricing Trends (2018-2029)
1.3 World Huntington's Disease Treatment Production by Region (Based on Production Site)
1.3.1 World Huntington's Disease Treatment Production Value by Region (2018-2029)
1.3.2 World Huntington's Disease Treatment Production by Region (2018-2029)
1.3.3 World Huntington's Disease Treatment Average Price by Region (2018-2029)
1.3.4 North America Huntington's Disease Treatment Production (2018-2029)
1.3.5 Europe Huntington's Disease Treatment Production (2018-2029)
1.3.6 China Huntington's Disease Treatment Production (2018-2029)
1.3.7 Japan Huntington's Disease Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Huntington's Disease Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Huntington's Disease Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Huntington's Disease Treatment Demand (2018-2029)
2.2 World Huntington's Disease Treatment Consumption by Region
2.2.1 World Huntington's Disease Treatment Consumption by Region (2018-2023)
2.2.2 World Huntington's Disease Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Huntington's Disease Treatment Consumption (2018-2029)
2.4 China Huntington's Disease Treatment Consumption (2018-2029)
2.5 Europe Huntington's Disease Treatment Consumption (2018-2029)
2.6 Japan Huntington's Disease Treatment Consumption (2018-2029)
2.7 South Korea Huntington's Disease Treatment Consumption (2018-2029)
2.8 ASEAN Huntington's Disease Treatment Consumption (2018-2029)
2.9 India Huntington's Disease Treatment Consumption (2018-2029)
3 WORLD HUNTINGTON'S DISEASE TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Huntington's Disease Treatment Production Value by Manufacturer (2018-2023)
3.2 World Huntington's Disease Treatment Production by Manufacturer (2018-2023)
3.3 World Huntington's Disease Treatment Average Price by Manufacturer (2018-2023)
3.4 Huntington's Disease Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Huntington's Disease Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Huntington's Disease Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Huntington's Disease Treatment in 2022
3.6 Huntington's Disease Treatment Market: Overall Company Footprint Analysis
3.6.1 Huntington's Disease Treatment Market: Region Footprint
3.6.2 Huntington's Disease Treatment Market: Company Product Type Footprint
3.6.3 Huntington's Disease Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Huntington's Disease Treatment Production Value Comparison
4.1.1 United States VS China: Huntington's Disease Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Huntington's Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Huntington's Disease Treatment Production Comparison
4.2.1 United States VS China: Huntington's Disease Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Huntington's Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Huntington's Disease Treatment Consumption Comparison
4.3.1 United States VS China: Huntington's Disease Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Huntington's Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Huntington's Disease Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Huntington's Disease Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Huntington's Disease Treatment Production (2018-2023)
4.5 China Based Huntington's Disease Treatment Manufacturers and Market Share
4.5.1 China Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Huntington's Disease Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Huntington's Disease Treatment Production (2018-2023)
4.6 Rest of World Based Huntington's Disease Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Huntington's Disease Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Huntington's Disease Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Huntington's Disease Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tetrabenazine
5.2.2 Selective Serotonin Reuptake Inhibitor
5.2.3 Chlorpromazine
5.2.4 Haloperidol
5.2.5 Risperidone
5.2.6 Olanzapine
5.2.7 Clozapine
5.2.8 Other
5.3 Market Segment by Type
5.3.1 World Huntington's Disease Treatment Production by Type (2018-2029)
5.3.2 World Huntington's Disease Treatment Production Value by Type (2018-2029)
5.3.3 World Huntington's Disease Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Huntington's Disease Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialty Clinic
6.2.3 other
6.3 Market Segment by Application
6.3.1 World Huntington's Disease Treatment Production by Application (2018-2029)
6.3.2 World Huntington's Disease Treatment Production Value by Application (2018-2029)
6.3.3 World Huntington's Disease Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AInylam Pharmaceuticals Inc
7.1.1 AInylam Pharmaceuticals Inc Details
7.1.2 AInylam Pharmaceuticals Inc Major Business
7.1.3 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
7.1.4 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AInylam Pharmaceuticals Inc Recent Developments/Updates
7.1.6 AInylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.2 AmpliPhi Biosciences Corp
7.2.1 AmpliPhi Biosciences Corp Details
7.2.2 AmpliPhi Biosciences Corp Major Business
7.2.3 AmpliPhi Biosciences Corp Huntington's Disease Treatment Product and Services
7.2.4 AmpliPhi Biosciences Corp Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AmpliPhi Biosciences Corp Recent Developments/Updates
7.2.6 AmpliPhi Biosciences Corp Competitive Strengths & Weaknesses
7.3 Ceregene Inc
7.3.1 Ceregene Inc Details
7.3.2 Ceregene Inc Major Business
7.3.3 Ceregene Inc Huntington's Disease Treatment Product and Services
7.3.4 Ceregene Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Ceregene Inc Recent Developments/Updates
7.3.6 Ceregene Inc Competitive Strengths & Weaknesses
7.4 Lundbeck
7.4.1 Lundbeck Details
7.4.2 Lundbeck Major Business
7.4.3 Lundbeck Huntington's Disease Treatment Product and Services
7.4.4 Lundbeck Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Lundbeck Recent Developments/Updates
7.4.6 Lundbeck Competitive Strengths & Weaknesses
7.5 Prana Biotechnology Limited
7.5.1 Prana Biotechnology Limited Details
7.5.2 Prana Biotechnology Limited Major Business
7.5.3 Prana Biotechnology Limited Huntington's Disease Treatment Product and Services
7.5.4 Prana Biotechnology Limited Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Prana Biotechnology Limited Recent Developments/Updates
7.5.6 Prana Biotechnology Limited Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Teva Pharmaceutical Industries Ltd Details
7.6.2 Teva Pharmaceutical Industries Ltd Major Business
7.6.3 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product and Services
7.6.4 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.6.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.7 Cortex Pharmaceuticals Inc
7.7.1 Cortex Pharmaceuticals Inc Details
7.7.2 Cortex Pharmaceuticals Inc Major Business
7.7.3 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
7.7.4 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Cortex Pharmaceuticals Inc Recent Developments/Updates
7.7.6 Cortex Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.8 Vertex Pharmaceuticals Incorporated
7.8.1 Vertex Pharmaceuticals Incorporated Details
7.8.2 Vertex Pharmaceuticals Incorporated Major Business
7.8.3 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product and Services
7.8.4 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Vertex Pharmaceuticals Incorporated Recent Developments/Updates
7.8.6 Vertex Pharmaceuticals Incorporated Competitive Strengths & Weaknesses
7.9 Auspex Pharmaceuticals
7.9.1 Auspex Pharmaceuticals Details
7.9.2 Auspex Pharmaceuticals Major Business
7.9.3 Auspex Pharmaceuticals Huntington's Disease Treatment Product and Services
7.9.4 Auspex Pharmaceuticals Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Auspex Pharmaceuticals Recent Developments/Updates
7.9.6 Auspex Pharmaceuticals Competitive Strengths & Weaknesses
7.10 SOM Biotech
7.10.1 SOM Biotech Details
7.10.2 SOM Biotech Major Business
7.10.3 SOM Biotech Huntington's Disease Treatment Product and Services
7.10.4 SOM Biotech Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 SOM Biotech Recent Developments/Updates
7.10.6 SOM Biotech Competitive Strengths & Weaknesses
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Details
7.11.2 GlaxoSmithKline Major Business
7.11.3 GlaxoSmithKline Huntington's Disease Treatment Product and Services
7.11.4 GlaxoSmithKline Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 GlaxoSmithKline Recent Developments/Updates
7.11.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.12 Siena Biotech
7.12.1 Siena Biotech Details
7.12.2 Siena Biotech Major Business
7.12.3 Siena Biotech Huntington's Disease Treatment Product and Services
7.12.4 Siena Biotech Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Siena Biotech Recent Developments/Updates
7.12.6 Siena Biotech Competitive Strengths & Weaknesses
7.13 Raptor Pharmaceutical
7.13.1 Raptor Pharmaceutical Details
7.13.2 Raptor Pharmaceutical Major Business
7.13.3 Raptor Pharmaceutical Huntington's Disease Treatment Product and Services
7.13.4 Raptor Pharmaceutical Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Raptor Pharmaceutical Recent Developments/Updates
7.13.6 Raptor Pharmaceutical Competitive Strengths & Weaknesses
7.14 Pfizer
7.14.1 Pfizer Details
7.14.2 Pfizer Major Business
7.14.3 Pfizer Huntington's Disease Treatment Product and Services
7.14.4 Pfizer Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Pfizer Recent Developments/Updates
7.14.6 Pfizer Competitive Strengths & Weaknesses
7.15 Palobiofarma
7.15.1 Palobiofarma Details
7.15.2 Palobiofarma Major Business
7.15.3 Palobiofarma Huntington's Disease Treatment Product and Services
7.15.4 Palobiofarma Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Palobiofarma Recent Developments/Updates
7.15.6 Palobiofarma Competitive Strengths & Weaknesses
7.16 Omeros
7.16.1 Omeros Details
7.16.2 Omeros Major Business
7.16.3 Omeros Huntington's Disease Treatment Product and Services
7.16.4 Omeros Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Omeros Recent Developments/Updates
7.16.6 Omeros Competitive Strengths & Weaknesses
7.17 Ipsen
7.17.1 Ipsen Details
7.17.2 Ipsen Major Business
7.17.3 Ipsen Huntington's Disease Treatment Product and Services
7.17.4 Ipsen Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Ipsen Recent Developments/Updates
7.17.6 Ipsen Competitive Strengths & Weaknesses
7.18 Valeant Pharmaceuticals International Inc
7.18.1 Valeant Pharmaceuticals International Inc Details
7.18.2 Valeant Pharmaceuticals International Inc Major Business
7.18.3 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product and Services
7.18.4 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Valeant Pharmaceuticals International Inc Recent Developments/Updates
7.18.6 Valeant Pharmaceuticals International Inc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Huntington's Disease Treatment Industry Chain
8.2 Huntington's Disease Treatment Upstream Analysis
8.2.1 Huntington's Disease Treatment Core Raw Materials
8.2.2 Main Manufacturers of Huntington's Disease Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Huntington's Disease Treatment Production Mode
8.6 Huntington's Disease Treatment Procurement Model
8.7 Huntington's Disease Treatment Industry Sales Model and Sales Channels
8.7.1 Huntington's Disease Treatment Sales Model
8.7.2 Huntington's Disease Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Huntington's Disease Treatment Introduction
1.2 World Huntington's Disease Treatment Supply & Forecast
1.2.1 World Huntington's Disease Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Huntington's Disease Treatment Production (2018-2029)
1.2.3 World Huntington's Disease Treatment Pricing Trends (2018-2029)
1.3 World Huntington's Disease Treatment Production by Region (Based on Production Site)
1.3.1 World Huntington's Disease Treatment Production Value by Region (2018-2029)
1.3.2 World Huntington's Disease Treatment Production by Region (2018-2029)
1.3.3 World Huntington's Disease Treatment Average Price by Region (2018-2029)
1.3.4 North America Huntington's Disease Treatment Production (2018-2029)
1.3.5 Europe Huntington's Disease Treatment Production (2018-2029)
1.3.6 China Huntington's Disease Treatment Production (2018-2029)
1.3.7 Japan Huntington's Disease Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Huntington's Disease Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Huntington's Disease Treatment Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Huntington's Disease Treatment Demand (2018-2029)
2.2 World Huntington's Disease Treatment Consumption by Region
2.2.1 World Huntington's Disease Treatment Consumption by Region (2018-2023)
2.2.2 World Huntington's Disease Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Huntington's Disease Treatment Consumption (2018-2029)
2.4 China Huntington's Disease Treatment Consumption (2018-2029)
2.5 Europe Huntington's Disease Treatment Consumption (2018-2029)
2.6 Japan Huntington's Disease Treatment Consumption (2018-2029)
2.7 South Korea Huntington's Disease Treatment Consumption (2018-2029)
2.8 ASEAN Huntington's Disease Treatment Consumption (2018-2029)
2.9 India Huntington's Disease Treatment Consumption (2018-2029)
3 WORLD HUNTINGTON'S DISEASE TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Huntington's Disease Treatment Production Value by Manufacturer (2018-2023)
3.2 World Huntington's Disease Treatment Production by Manufacturer (2018-2023)
3.3 World Huntington's Disease Treatment Average Price by Manufacturer (2018-2023)
3.4 Huntington's Disease Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Huntington's Disease Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Huntington's Disease Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Huntington's Disease Treatment in 2022
3.6 Huntington's Disease Treatment Market: Overall Company Footprint Analysis
3.6.1 Huntington's Disease Treatment Market: Region Footprint
3.6.2 Huntington's Disease Treatment Market: Company Product Type Footprint
3.6.3 Huntington's Disease Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Huntington's Disease Treatment Production Value Comparison
4.1.1 United States VS China: Huntington's Disease Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Huntington's Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Huntington's Disease Treatment Production Comparison
4.2.1 United States VS China: Huntington's Disease Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Huntington's Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Huntington's Disease Treatment Consumption Comparison
4.3.1 United States VS China: Huntington's Disease Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Huntington's Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Huntington's Disease Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Huntington's Disease Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Huntington's Disease Treatment Production (2018-2023)
4.5 China Based Huntington's Disease Treatment Manufacturers and Market Share
4.5.1 China Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Huntington's Disease Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Huntington's Disease Treatment Production (2018-2023)
4.6 Rest of World Based Huntington's Disease Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Huntington's Disease Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Huntington's Disease Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Huntington's Disease Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tetrabenazine
5.2.2 Selective Serotonin Reuptake Inhibitor
5.2.3 Chlorpromazine
5.2.4 Haloperidol
5.2.5 Risperidone
5.2.6 Olanzapine
5.2.7 Clozapine
5.2.8 Other
5.3 Market Segment by Type
5.3.1 World Huntington's Disease Treatment Production by Type (2018-2029)
5.3.2 World Huntington's Disease Treatment Production Value by Type (2018-2029)
5.3.3 World Huntington's Disease Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Huntington's Disease Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialty Clinic
6.2.3 other
6.3 Market Segment by Application
6.3.1 World Huntington's Disease Treatment Production by Application (2018-2029)
6.3.2 World Huntington's Disease Treatment Production Value by Application (2018-2029)
6.3.3 World Huntington's Disease Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AInylam Pharmaceuticals Inc
7.1.1 AInylam Pharmaceuticals Inc Details
7.1.2 AInylam Pharmaceuticals Inc Major Business
7.1.3 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
7.1.4 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AInylam Pharmaceuticals Inc Recent Developments/Updates
7.1.6 AInylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.2 AmpliPhi Biosciences Corp
7.2.1 AmpliPhi Biosciences Corp Details
7.2.2 AmpliPhi Biosciences Corp Major Business
7.2.3 AmpliPhi Biosciences Corp Huntington's Disease Treatment Product and Services
7.2.4 AmpliPhi Biosciences Corp Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AmpliPhi Biosciences Corp Recent Developments/Updates
7.2.6 AmpliPhi Biosciences Corp Competitive Strengths & Weaknesses
7.3 Ceregene Inc
7.3.1 Ceregene Inc Details
7.3.2 Ceregene Inc Major Business
7.3.3 Ceregene Inc Huntington's Disease Treatment Product and Services
7.3.4 Ceregene Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Ceregene Inc Recent Developments/Updates
7.3.6 Ceregene Inc Competitive Strengths & Weaknesses
7.4 Lundbeck
7.4.1 Lundbeck Details
7.4.2 Lundbeck Major Business
7.4.3 Lundbeck Huntington's Disease Treatment Product and Services
7.4.4 Lundbeck Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Lundbeck Recent Developments/Updates
7.4.6 Lundbeck Competitive Strengths & Weaknesses
7.5 Prana Biotechnology Limited
7.5.1 Prana Biotechnology Limited Details
7.5.2 Prana Biotechnology Limited Major Business
7.5.3 Prana Biotechnology Limited Huntington's Disease Treatment Product and Services
7.5.4 Prana Biotechnology Limited Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Prana Biotechnology Limited Recent Developments/Updates
7.5.6 Prana Biotechnology Limited Competitive Strengths & Weaknesses
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Teva Pharmaceutical Industries Ltd Details
7.6.2 Teva Pharmaceutical Industries Ltd Major Business
7.6.3 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product and Services
7.6.4 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.6.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.7 Cortex Pharmaceuticals Inc
7.7.1 Cortex Pharmaceuticals Inc Details
7.7.2 Cortex Pharmaceuticals Inc Major Business
7.7.3 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
7.7.4 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Cortex Pharmaceuticals Inc Recent Developments/Updates
7.7.6 Cortex Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.8 Vertex Pharmaceuticals Incorporated
7.8.1 Vertex Pharmaceuticals Incorporated Details
7.8.2 Vertex Pharmaceuticals Incorporated Major Business
7.8.3 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product and Services
7.8.4 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Vertex Pharmaceuticals Incorporated Recent Developments/Updates
7.8.6 Vertex Pharmaceuticals Incorporated Competitive Strengths & Weaknesses
7.9 Auspex Pharmaceuticals
7.9.1 Auspex Pharmaceuticals Details
7.9.2 Auspex Pharmaceuticals Major Business
7.9.3 Auspex Pharmaceuticals Huntington's Disease Treatment Product and Services
7.9.4 Auspex Pharmaceuticals Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Auspex Pharmaceuticals Recent Developments/Updates
7.9.6 Auspex Pharmaceuticals Competitive Strengths & Weaknesses
7.10 SOM Biotech
7.10.1 SOM Biotech Details
7.10.2 SOM Biotech Major Business
7.10.3 SOM Biotech Huntington's Disease Treatment Product and Services
7.10.4 SOM Biotech Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 SOM Biotech Recent Developments/Updates
7.10.6 SOM Biotech Competitive Strengths & Weaknesses
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Details
7.11.2 GlaxoSmithKline Major Business
7.11.3 GlaxoSmithKline Huntington's Disease Treatment Product and Services
7.11.4 GlaxoSmithKline Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 GlaxoSmithKline Recent Developments/Updates
7.11.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.12 Siena Biotech
7.12.1 Siena Biotech Details
7.12.2 Siena Biotech Major Business
7.12.3 Siena Biotech Huntington's Disease Treatment Product and Services
7.12.4 Siena Biotech Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Siena Biotech Recent Developments/Updates
7.12.6 Siena Biotech Competitive Strengths & Weaknesses
7.13 Raptor Pharmaceutical
7.13.1 Raptor Pharmaceutical Details
7.13.2 Raptor Pharmaceutical Major Business
7.13.3 Raptor Pharmaceutical Huntington's Disease Treatment Product and Services
7.13.4 Raptor Pharmaceutical Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Raptor Pharmaceutical Recent Developments/Updates
7.13.6 Raptor Pharmaceutical Competitive Strengths & Weaknesses
7.14 Pfizer
7.14.1 Pfizer Details
7.14.2 Pfizer Major Business
7.14.3 Pfizer Huntington's Disease Treatment Product and Services
7.14.4 Pfizer Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Pfizer Recent Developments/Updates
7.14.6 Pfizer Competitive Strengths & Weaknesses
7.15 Palobiofarma
7.15.1 Palobiofarma Details
7.15.2 Palobiofarma Major Business
7.15.3 Palobiofarma Huntington's Disease Treatment Product and Services
7.15.4 Palobiofarma Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Palobiofarma Recent Developments/Updates
7.15.6 Palobiofarma Competitive Strengths & Weaknesses
7.16 Omeros
7.16.1 Omeros Details
7.16.2 Omeros Major Business
7.16.3 Omeros Huntington's Disease Treatment Product and Services
7.16.4 Omeros Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Omeros Recent Developments/Updates
7.16.6 Omeros Competitive Strengths & Weaknesses
7.17 Ipsen
7.17.1 Ipsen Details
7.17.2 Ipsen Major Business
7.17.3 Ipsen Huntington's Disease Treatment Product and Services
7.17.4 Ipsen Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Ipsen Recent Developments/Updates
7.17.6 Ipsen Competitive Strengths & Weaknesses
7.18 Valeant Pharmaceuticals International Inc
7.18.1 Valeant Pharmaceuticals International Inc Details
7.18.2 Valeant Pharmaceuticals International Inc Major Business
7.18.3 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product and Services
7.18.4 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Valeant Pharmaceuticals International Inc Recent Developments/Updates
7.18.6 Valeant Pharmaceuticals International Inc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Huntington's Disease Treatment Industry Chain
8.2 Huntington's Disease Treatment Upstream Analysis
8.2.1 Huntington's Disease Treatment Core Raw Materials
8.2.2 Main Manufacturers of Huntington's Disease Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Huntington's Disease Treatment Production Mode
8.6 Huntington's Disease Treatment Procurement Model
8.7 Huntington's Disease Treatment Industry Sales Model and Sales Channels
8.7.1 Huntington's Disease Treatment Sales Model
8.7.2 Huntington's Disease Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Huntington's Disease Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Huntington's Disease Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Huntington's Disease Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Huntington's Disease Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Huntington's Disease Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Huntington's Disease Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Huntington's Disease Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Huntington's Disease Treatment Production Market Share by Region (2018-2023)
Table 9. World Huntington's Disease Treatment Production Market Share by Region (2024-2029)
Table 10. World Huntington's Disease Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Huntington's Disease Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Huntington's Disease Treatment Major Market Trends
Table 13. World Huntington's Disease Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Huntington's Disease Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Huntington's Disease Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Huntington's Disease Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Huntington's Disease Treatment Producers in 2022
Table 18. World Huntington's Disease Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Huntington's Disease Treatment Producers in 2022
Table 20. World Huntington's Disease Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Huntington's Disease Treatment Company Evaluation Quadrant
Table 22. World Huntington's Disease Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Huntington's Disease Treatment Production Site of Key Manufacturer
Table 24. Huntington's Disease Treatment Market: Company Product Type Footprint
Table 25. Huntington's Disease Treatment Market: Company Product Application Footprint
Table 26. Huntington's Disease Treatment Competitive Factors
Table 27. Huntington's Disease Treatment New Entrant and Capacity Expansion Plans
Table 28. Huntington's Disease Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Huntington's Disease Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Huntington's Disease Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Huntington's Disease Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Huntington's Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Huntington's Disease Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Huntington's Disease Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Huntington's Disease Treatment Production Market Share (2018-2023)
Table 37. China Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Huntington's Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Huntington's Disease Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Huntington's Disease Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Huntington's Disease Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Huntington's Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Huntington's Disease Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Huntington's Disease Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Huntington's Disease Treatment Production Market Share (2018-2023)
Table 47. World Huntington's Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Huntington's Disease Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Huntington's Disease Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Huntington's Disease Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Huntington's Disease Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Huntington's Disease Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Huntington's Disease Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Huntington's Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Huntington's Disease Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Huntington's Disease Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Huntington's Disease Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Huntington's Disease Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Huntington's Disease Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Huntington's Disease Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AInylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 62. AInylam Pharmaceuticals Inc Major Business
Table 63. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
Table 64. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AInylam Pharmaceuticals Inc Recent Developments/Updates
Table 66. AInylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 67. AmpliPhi Biosciences Corp Basic Information, Manufacturing Base and Competitors
Table 68. AmpliPhi Biosciences Corp Major Business
Table 69. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product and Services
Table 70. AmpliPhi Biosciences Corp Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AmpliPhi Biosciences Corp Recent Developments/Updates
Table 72. AmpliPhi Biosciences Corp Competitive Strengths & Weaknesses
Table 73. Ceregene Inc Basic Information, Manufacturing Base and Competitors
Table 74. Ceregene Inc Major Business
Table 75. Ceregene Inc Huntington's Disease Treatment Product and Services
Table 76. Ceregene Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Ceregene Inc Recent Developments/Updates
Table 78. Ceregene Inc Competitive Strengths & Weaknesses
Table 79. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 80. Lundbeck Major Business
Table 81. Lundbeck Huntington's Disease Treatment Product and Services
Table 82. Lundbeck Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Lundbeck Recent Developments/Updates
Table 84. Lundbeck Competitive Strengths & Weaknesses
Table 85. Prana Biotechnology Limited Basic Information, Manufacturing Base and Competitors
Table 86. Prana Biotechnology Limited Major Business
Table 87. Prana Biotechnology Limited Huntington's Disease Treatment Product and Services
Table 88. Prana Biotechnology Limited Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Prana Biotechnology Limited Recent Developments/Updates
Table 90. Prana Biotechnology Limited Competitive Strengths & Weaknesses
Table 91. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Teva Pharmaceutical Industries Ltd Major Business
Table 93. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product and Services
Table 94. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 96. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 97. Cortex Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 98. Cortex Pharmaceuticals Inc Major Business
Table 99. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
Table 100. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Cortex Pharmaceuticals Inc Recent Developments/Updates
Table 102. Cortex Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 103. Vertex Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors
Table 104. Vertex Pharmaceuticals Incorporated Major Business
Table 105. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product and Services
Table 106. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Vertex Pharmaceuticals Incorporated Recent Developments/Updates
Table 108. Vertex Pharmaceuticals Incorporated Competitive Strengths & Weaknesses
Table 109. Auspex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Auspex Pharmaceuticals Major Business
Table 111. Auspex Pharmaceuticals Huntington's Disease Treatment Product and Services
Table 112. Auspex Pharmaceuticals Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Auspex Pharmaceuticals Recent Developments/Updates
Table 114. Auspex Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. SOM Biotech Basic Information, Manufacturing Base and Competitors
Table 116. SOM Biotech Major Business
Table 117. SOM Biotech Huntington's Disease Treatment Product and Services
Table 118. SOM Biotech Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. SOM Biotech Recent Developments/Updates
Table 120. SOM Biotech Competitive Strengths & Weaknesses
Table 121. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 122. GlaxoSmithKline Major Business
Table 123. GlaxoSmithKline Huntington's Disease Treatment Product and Services
Table 124. GlaxoSmithKline Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. GlaxoSmithKline Recent Developments/Updates
Table 126. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 127. Siena Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Siena Biotech Major Business
Table 129. Siena Biotech Huntington's Disease Treatment Product and Services
Table 130. Siena Biotech Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Siena Biotech Recent Developments/Updates
Table 132. Siena Biotech Competitive Strengths & Weaknesses
Table 133. Raptor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Raptor Pharmaceutical Major Business
Table 135. Raptor Pharmaceutical Huntington's Disease Treatment Product and Services
Table 136. Raptor Pharmaceutical Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Raptor Pharmaceutical Recent Developments/Updates
Table 138. Raptor Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Pfizer Basic Information, Manufacturing Base and Competitors
Table 140. Pfizer Major Business
Table 141. Pfizer Huntington's Disease Treatment Product and Services
Table 142. Pfizer Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Pfizer Recent Developments/Updates
Table 144. Pfizer Competitive Strengths & Weaknesses
Table 145. Palobiofarma Basic Information, Manufacturing Base and Competitors
Table 146. Palobiofarma Major Business
Table 147. Palobiofarma Huntington's Disease Treatment Product and Services
Table 148. Palobiofarma Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Palobiofarma Recent Developments/Updates
Table 150. Palobiofarma Competitive Strengths & Weaknesses
Table 151. Omeros Basic Information, Manufacturing Base and Competitors
Table 152. Omeros Major Business
Table 153. Omeros Huntington's Disease Treatment Product and Services
Table 154. Omeros Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Omeros Recent Developments/Updates
Table 156. Omeros Competitive Strengths & Weaknesses
Table 157. Ipsen Basic Information, Manufacturing Base and Competitors
Table 158. Ipsen Major Business
Table 159. Ipsen Huntington's Disease Treatment Product and Services
Table 160. Ipsen Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Ipsen Recent Developments/Updates
Table 162. Valeant Pharmaceuticals International Inc Basic Information, Manufacturing Base and Competitors
Table 163. Valeant Pharmaceuticals International Inc Major Business
Table 164. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product and Services
Table 165. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 166. Global Key Players of Huntington's Disease Treatment Upstream (Raw Materials)
Table 167. Huntington's Disease Treatment Typical Customers
Table 168. Huntington's Disease Treatment Typical Distributors
Table 1. World Huntington's Disease Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Huntington's Disease Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Huntington's Disease Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Huntington's Disease Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Huntington's Disease Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Huntington's Disease Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Huntington's Disease Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Huntington's Disease Treatment Production Market Share by Region (2018-2023)
Table 9. World Huntington's Disease Treatment Production Market Share by Region (2024-2029)
Table 10. World Huntington's Disease Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Huntington's Disease Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Huntington's Disease Treatment Major Market Trends
Table 13. World Huntington's Disease Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Huntington's Disease Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Huntington's Disease Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Huntington's Disease Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Huntington's Disease Treatment Producers in 2022
Table 18. World Huntington's Disease Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Huntington's Disease Treatment Producers in 2022
Table 20. World Huntington's Disease Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Huntington's Disease Treatment Company Evaluation Quadrant
Table 22. World Huntington's Disease Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Huntington's Disease Treatment Production Site of Key Manufacturer
Table 24. Huntington's Disease Treatment Market: Company Product Type Footprint
Table 25. Huntington's Disease Treatment Market: Company Product Application Footprint
Table 26. Huntington's Disease Treatment Competitive Factors
Table 27. Huntington's Disease Treatment New Entrant and Capacity Expansion Plans
Table 28. Huntington's Disease Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Huntington's Disease Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Huntington's Disease Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Huntington's Disease Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Huntington's Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Huntington's Disease Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Huntington's Disease Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Huntington's Disease Treatment Production Market Share (2018-2023)
Table 37. China Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Huntington's Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Huntington's Disease Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Huntington's Disease Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Huntington's Disease Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Huntington's Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Huntington's Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Huntington's Disease Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Huntington's Disease Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Huntington's Disease Treatment Production Market Share (2018-2023)
Table 47. World Huntington's Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Huntington's Disease Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Huntington's Disease Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Huntington's Disease Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Huntington's Disease Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Huntington's Disease Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Huntington's Disease Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Huntington's Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Huntington's Disease Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Huntington's Disease Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Huntington's Disease Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Huntington's Disease Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Huntington's Disease Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Huntington's Disease Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AInylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 62. AInylam Pharmaceuticals Inc Major Business
Table 63. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
Table 64. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AInylam Pharmaceuticals Inc Recent Developments/Updates
Table 66. AInylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 67. AmpliPhi Biosciences Corp Basic Information, Manufacturing Base and Competitors
Table 68. AmpliPhi Biosciences Corp Major Business
Table 69. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product and Services
Table 70. AmpliPhi Biosciences Corp Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AmpliPhi Biosciences Corp Recent Developments/Updates
Table 72. AmpliPhi Biosciences Corp Competitive Strengths & Weaknesses
Table 73. Ceregene Inc Basic Information, Manufacturing Base and Competitors
Table 74. Ceregene Inc Major Business
Table 75. Ceregene Inc Huntington's Disease Treatment Product and Services
Table 76. Ceregene Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Ceregene Inc Recent Developments/Updates
Table 78. Ceregene Inc Competitive Strengths & Weaknesses
Table 79. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 80. Lundbeck Major Business
Table 81. Lundbeck Huntington's Disease Treatment Product and Services
Table 82. Lundbeck Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Lundbeck Recent Developments/Updates
Table 84. Lundbeck Competitive Strengths & Weaknesses
Table 85. Prana Biotechnology Limited Basic Information, Manufacturing Base and Competitors
Table 86. Prana Biotechnology Limited Major Business
Table 87. Prana Biotechnology Limited Huntington's Disease Treatment Product and Services
Table 88. Prana Biotechnology Limited Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Prana Biotechnology Limited Recent Developments/Updates
Table 90. Prana Biotechnology Limited Competitive Strengths & Weaknesses
Table 91. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Teva Pharmaceutical Industries Ltd Major Business
Table 93. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product and Services
Table 94. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 96. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 97. Cortex Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 98. Cortex Pharmaceuticals Inc Major Business
Table 99. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product and Services
Table 100. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Cortex Pharmaceuticals Inc Recent Developments/Updates
Table 102. Cortex Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 103. Vertex Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors
Table 104. Vertex Pharmaceuticals Incorporated Major Business
Table 105. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product and Services
Table 106. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Vertex Pharmaceuticals Incorporated Recent Developments/Updates
Table 108. Vertex Pharmaceuticals Incorporated Competitive Strengths & Weaknesses
Table 109. Auspex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Auspex Pharmaceuticals Major Business
Table 111. Auspex Pharmaceuticals Huntington's Disease Treatment Product and Services
Table 112. Auspex Pharmaceuticals Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Auspex Pharmaceuticals Recent Developments/Updates
Table 114. Auspex Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. SOM Biotech Basic Information, Manufacturing Base and Competitors
Table 116. SOM Biotech Major Business
Table 117. SOM Biotech Huntington's Disease Treatment Product and Services
Table 118. SOM Biotech Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. SOM Biotech Recent Developments/Updates
Table 120. SOM Biotech Competitive Strengths & Weaknesses
Table 121. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 122. GlaxoSmithKline Major Business
Table 123. GlaxoSmithKline Huntington's Disease Treatment Product and Services
Table 124. GlaxoSmithKline Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. GlaxoSmithKline Recent Developments/Updates
Table 126. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 127. Siena Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Siena Biotech Major Business
Table 129. Siena Biotech Huntington's Disease Treatment Product and Services
Table 130. Siena Biotech Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Siena Biotech Recent Developments/Updates
Table 132. Siena Biotech Competitive Strengths & Weaknesses
Table 133. Raptor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Raptor Pharmaceutical Major Business
Table 135. Raptor Pharmaceutical Huntington's Disease Treatment Product and Services
Table 136. Raptor Pharmaceutical Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Raptor Pharmaceutical Recent Developments/Updates
Table 138. Raptor Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Pfizer Basic Information, Manufacturing Base and Competitors
Table 140. Pfizer Major Business
Table 141. Pfizer Huntington's Disease Treatment Product and Services
Table 142. Pfizer Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Pfizer Recent Developments/Updates
Table 144. Pfizer Competitive Strengths & Weaknesses
Table 145. Palobiofarma Basic Information, Manufacturing Base and Competitors
Table 146. Palobiofarma Major Business
Table 147. Palobiofarma Huntington's Disease Treatment Product and Services
Table 148. Palobiofarma Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Palobiofarma Recent Developments/Updates
Table 150. Palobiofarma Competitive Strengths & Weaknesses
Table 151. Omeros Basic Information, Manufacturing Base and Competitors
Table 152. Omeros Major Business
Table 153. Omeros Huntington's Disease Treatment Product and Services
Table 154. Omeros Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Omeros Recent Developments/Updates
Table 156. Omeros Competitive Strengths & Weaknesses
Table 157. Ipsen Basic Information, Manufacturing Base and Competitors
Table 158. Ipsen Major Business
Table 159. Ipsen Huntington's Disease Treatment Product and Services
Table 160. Ipsen Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Ipsen Recent Developments/Updates
Table 162. Valeant Pharmaceuticals International Inc Basic Information, Manufacturing Base and Competitors
Table 163. Valeant Pharmaceuticals International Inc Major Business
Table 164. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product and Services
Table 165. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 166. Global Key Players of Huntington's Disease Treatment Upstream (Raw Materials)
Table 167. Huntington's Disease Treatment Typical Customers
Table 168. Huntington's Disease Treatment Typical Distributors
LIST OF FIGURES
Figure 1. Huntington's Disease Treatment Picture
Figure 2. World Huntington's Disease Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Huntington's Disease Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 5. World Huntington's Disease Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Huntington's Disease Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Huntington's Disease Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 10. China Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 12. Huntington's Disease Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Huntington's Disease Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Huntington's Disease Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Huntington's Disease Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Huntington's Disease Treatment Markets in 2022
Figure 26. United States VS China: Huntington's Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Huntington's Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Huntington's Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Huntington's Disease Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Huntington's Disease Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Huntington's Disease Treatment Production Market Share 2022
Figure 32. World Huntington's Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Huntington's Disease Treatment Production Value Market Share by Type in 2022
Figure 34. Tetrabenazine
Figure 35. Selective Serotonin Reuptake Inhibitor
Figure 36. Chlorpromazine
Figure 37. Haloperidol
Figure 38. Risperidone
Figure 39. Olanzapine
Figure 40. Clozapine
Figure 41. Other
Figure 42. World Huntington's Disease Treatment Production Market Share by Type (2018-2029)
Figure 43. World Huntington's Disease Treatment Production Value Market Share by Type (2018-2029)
Figure 44. World Huntington's Disease Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 45. World Huntington's Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 46. World Huntington's Disease Treatment Production Value Market Share by Application in 2022
Figure 47. Hospital
Figure 48. Specialty Clinic
Figure 49. other
Figure 50. World Huntington's Disease Treatment Production Market Share by Application (2018-2029)
Figure 51. World Huntington's Disease Treatment Production Value Market Share by Application (2018-2029)
Figure 52. World Huntington's Disease Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Huntington's Disease Treatment Industry Chain
Figure 54. Huntington's Disease Treatment Procurement Model
Figure 55. Huntington's Disease Treatment Sales Model
Figure 56. Huntington's Disease Treatment Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Huntington's Disease Treatment Picture
Figure 2. World Huntington's Disease Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Huntington's Disease Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 5. World Huntington's Disease Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Huntington's Disease Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Huntington's Disease Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 10. China Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Huntington's Disease Treatment Production (2018-2029) & (K Units)
Figure 12. Huntington's Disease Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Huntington's Disease Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Huntington's Disease Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Huntington's Disease Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Huntington's Disease Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Huntington's Disease Treatment Markets in 2022
Figure 26. United States VS China: Huntington's Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Huntington's Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Huntington's Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Huntington's Disease Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Huntington's Disease Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Huntington's Disease Treatment Production Market Share 2022
Figure 32. World Huntington's Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Huntington's Disease Treatment Production Value Market Share by Type in 2022
Figure 34. Tetrabenazine
Figure 35. Selective Serotonin Reuptake Inhibitor
Figure 36. Chlorpromazine
Figure 37. Haloperidol
Figure 38. Risperidone
Figure 39. Olanzapine
Figure 40. Clozapine
Figure 41. Other
Figure 42. World Huntington's Disease Treatment Production Market Share by Type (2018-2029)
Figure 43. World Huntington's Disease Treatment Production Value Market Share by Type (2018-2029)
Figure 44. World Huntington's Disease Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 45. World Huntington's Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 46. World Huntington's Disease Treatment Production Value Market Share by Application in 2022
Figure 47. Hospital
Figure 48. Specialty Clinic
Figure 49. other
Figure 50. World Huntington's Disease Treatment Production Market Share by Application (2018-2029)
Figure 51. World Huntington's Disease Treatment Production Value Market Share by Application (2018-2029)
Figure 52. World Huntington's Disease Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Huntington's Disease Treatment Industry Chain
Figure 54. Huntington's Disease Treatment Procurement Model
Figure 55. Huntington's Disease Treatment Sales Model
Figure 56. Huntington's Disease Treatment Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
